ZELCIRKO Trademark
Trademark Overview
On Wednesday, January 21, 2026, a trademark application was filed for ZELCIRKO with the United States Patent and Trademark Office. The USPTO has given the ZELCIRKO trademark a serial number of 99606771. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 5, 2026. This trademark is owned by Eli Lilly and Company. The ZELCIRKO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiometabolic diseases and disorders, cardiovascular diseases, central nervous system diseases and disorders, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerativ...
General Information
| Serial Number | 99606771 |
| Word Mark | ZELCIRKO |
| Filing Date | Wednesday, January 21, 2026 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, May 5, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 10, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiometabolic diseases and disorders, cardiovascular diseases, central nervous system diseases and disorders, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis and vascular diseases; pharmaceutical preparations for weight management |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 21, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, January 21, 2026 | NEW APPLICATION ENTERED |
| Wednesday, January 21, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 21, 2026 | APPLICATION FILING RECEIPT MAILED |
| Thursday, February 5, 2026 | ASSIGNED TO EXAMINER |
| Thursday, February 12, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 4, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 10, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 10, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 5, 2026 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
